The contracts are part of the NIH’s Rapid Acceleration of Diagnostics, or RADx, program it started in late April to speed the development of COVID-19 tests.
The money will support developing technologies for COVID-19 tests, such as portable point-of-care tests that can give immediate results. The new technologies will significantly increase the number, type and availability of tests by millions per week this fall, the NIH said.
The nine companies receiving the money are:
- MatMaCorp in Lincoln, Neb.
- Maxim Biomedical in Rockville, Md.
- MicroGEM International in Charlottesville, Va.
- Aegis Sciences in Nashville, Tenn.
- Broad Institute in Cambridge, Mass.
- Ceres Nanoscience in Manassas, Va.
- Illumina in San Diego
- PathGroup in Nashville, Tenn.
- Sonic Healthcare USA in Austin, Texas
Read the NIH’s full news release here.
More articles on supply chain:
Amazon’s delivery drones cleared for takeoff
US awards Abbott $760M contract for rapid COVID-19 tests
Medical device recalls rise 31% in Q2
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
